Eyeworld Supplements

2024 50 Years of ASCRS Supplement

This is a supplement to EyeWorld Magazine.

Issue link: https://supplements.eyeworld.org/i/1516004

Contents of this Issue

Navigation

Page 7 of 67

Alcon's unique PCIOL portfolio helps you offer patients full range of vision with both diffractive and non-diffractive IOLs. * Defined as modified Miyata grade 0, <25mv/mm 2 over 3 years (n=138), and over 9 years (n=20), respectively. PCIOL=Presbyopia Correcting IOL. † Results from a prospective, randomized, parallel group, subject- and assessor-masked, multisite trial of 107 subjects bilaterally implanted with the AcrySof ® IQ Vivity ® Extended Vision IOL and 113 with the AcrySof ® IQ IOL with 6 months follow-up. ‡ Snellen VA was converted from logMAR VA. A Snellen notation of 20/20-2 or better indicates a logMAR VA of 0.04 or better, which means 3 or more of the 5 ETDRS chart letters in the line were identified correctly. CLAREON® PANOPTIX® A full range of vision with exceptional clarity that lasts. 4,5 * CLAREON® VIVITY® The first and only non-diffractive wavefront shaping PCIOL with exceptional clarity, 1,2 * monofocal-quality distance visual acuity, excellent intermediate vision, and functional near vision. 3†‡ Learn more at ClareonIOL.com T H E C L A R E O N ® C O L L E C T I O N P R OV I D E S M O R E O P T I O N S F O R M O R E PAT I E N T S . MONOFOCAL | TORIC | VIVITY | PANOPTIX © 2024 Alcon Inc. US-SG-2400003

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld Supplements - 2024 50 Years of ASCRS Supplement